Brooke Army Medical Center opened a new Infusion Clinic to help high risk COVID-positive patients whose symptoms are mild to moderate.

The treatment involves IV infusion of investigational antibody medications that are not Food and Drug Administration approved, but are authorized under an FDA emergency use authorization.

“The goal of this treatment is to halt the progression of COVID, and to hopefully prevent inpatient admission,” said Air Force Maj. (Dr.) Joseph Yabes Jr., Infectious Disease Clinic officer in charge. “Overall people have had good responses to this therapy.”

Full Story